| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Author correction to ‘Multifunctional regulatory protein connective tissue growth factor (CTGF): A potential therapeutic target for diverse diseases’ [Acta pharmaceutica sinica B 12 (2022) 1740–1760]
|
Fu, Minyang
|
|
|
12 |
12 |
p. 4525
|
artikel
|
| 2 |
Biodegradable calcium sulfide-based nanomodulators for H2S-boosted Ca2+-involved synergistic cascade cancer therapy
|
Lin, Chuchu
|
|
|
12 |
12 |
p. 4472-4485
|
artikel
|
| 3 |
Co-delivery of nigericin and decitabine using hexahistidine-metal nanocarriers for pyroptosis-induced immunotherapeutics
|
Niu, Qiang
|
|
|
12 |
12 |
p. 4458-4471
|
artikel
|
| 4 |
Commentary: Acute psychological stress redistributed leukocytes via distinct brain circuits
|
Wu, Yan-Ping
|
|
|
12 |
12 |
p. 4522-4524
|
artikel
|
| 5 |
Cover Story
|
|
|
|
12 |
12 |
p. viii
|
artikel
|
| 6 |
Evolution of drug regulations and regulatory innovation for anticancer drugs in China
|
Liu, Yang
|
|
|
12 |
12 |
p. 4365-4377
|
artikel
|
| 7 |
Fully synthetic Tn-based three-component cancer vaccine using covalently linked TLR4 ligand MPLA and iNKT cell agonist KRN-7000 as built-in adjuvant effectively protects mice from tumor development
|
Yang, Deying
|
|
|
12 |
12 |
p. 4432-4445
|
artikel
|
| 8 |
Harnessing the cyclization strategy for new drug discovery
|
Tang, Kai
|
|
|
12 |
12 |
p. 4309-4326
|
artikel
|
| 9 |
Highly expressed SERCA2 triggers tumor cell autophagy and is a druggable vulnerability in triple-negative breast cancer
|
Fan, Minmin
|
|
|
12 |
12 |
p. 4407-4423
|
artikel
|
| 10 |
Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
|
Mao, Yuling
|
|
|
12 |
12 |
p. 4501-4518
|
artikel
|
| 11 |
Landscape of DILI-related adverse drug reaction in China Mainland
|
Wang, Jiabo
|
|
|
12 |
12 |
p. 4424-4431
|
artikel
|
| 12 |
Novel phthalimides regulating PD-1/PD-L1 interaction as potential immunotherapy agents
|
Sun, Chengliang
|
|
|
12 |
12 |
p. 4446-4457
|
artikel
|
| 13 |
Recent advances in bacteriophage-based therapeutics: Insight into the post-antibiotic era
|
Ling, Hao
|
|
|
12 |
12 |
p. 4348-4364
|
artikel
|
| 14 |
Repurposing of berbamine hydrochloride to inhibit Ebola virus by targeting viral glycoprotein
|
Yi, Dongrong
|
|
|
12 |
12 |
p. 4378-4389
|
artikel
|
| 15 |
Research and development of Chinese anti-COVID-19 drugs
|
Ji, Xiwei
|
|
|
12 |
12 |
p. 4271-4286
|
artikel
|
| 16 |
Small molecule-based immunomodulators for cancer therapy
|
Wu, Yinrong
|
|
|
12 |
12 |
p. 4287-4308
|
artikel
|
| 17 |
SMIP-30, a potent and selective PPM1A inhibitor with potential to treat tuberculosis
|
Xu, Shujing
|
|
|
12 |
12 |
p. 4519-4521
|
artikel
|
| 18 |
Spatio-temporal delivery of both intra- and extracellular toll-like receptor agonists for enhancing antigen-specific immune responses
|
Wang, Nannan
|
|
|
12 |
12 |
p. 4486-4500
|
artikel
|
| 19 |
Sphingosine kinase 1 promotes growth of glioblastoma by increasing inflammation mediated by the NF-κB /IL-6/STAT3 and JNK/PTX3 pathways
|
Li, Wan
|
|
|
12 |
12 |
p. 4390-4406
|
artikel
|
| 20 |
Table of Contents
|
|
|
|
12 |
12 |
p. iii-viii
|
artikel
|
| 21 |
Targeted nanomedicines remodeling immunosuppressive tumor microenvironment for enhanced cancer immunotherapy
|
Xu, Yanyan
|
|
|
12 |
12 |
p. 4327-4347
|
artikel
|
Tijdschrift beschrijving